Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2022-Q3
добавлен 14.11.2022
CASI Pharmaceuticals Мультипликаторы 2011-2024 | CASI
Мультипликаторы по годам CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-29.7 | -7.7 | -6.2 | -10.9 | -23.6 | -7.9 | -4.9 | -1.7 | -8.7 | -2.7 | -6.2 |
P/S |
36.1 | 24.5 | 69.0 | - | - | - | 734.4 | 1916.2 | - | 59.2 | 14.5 |
EPS |
-0.3 | -0.4 | -0.5 | -0.3 | -0.2 | -0.2 | -0.2 | -0.9 | -0.2 | -0.8 | -0.5 |
EV (Enterprise Value) |
1.08 млрд | 360 млн | 261 млн | 220 млн | 218 млн | 54.1 млн | 41.8 млн | 46.5 млн | 35.3 млн | 32.3 млн | 27.8 млн |
EBITDA per Share |
-0.304 | -0.272 | -0.394 | -0.293 | -0.173 | -0.167 | -0.218 | -0.226 | -0.219 | -0.235 | -0.385 |
EV/EBITDA |
-26.1 | -10.5 | -6.1 | -8.8 | -20.0 | -5.2 | -4.4 | -5.6 | -6.1 | -7.0 | -6.0 |
PEG |
-1.69 | 1.59 | 0.12 | 0.14 | 4.02 | -0.35 | -0.06 | 0.01 | -0.12 | 0.04 | -0.12 |
P/B |
10.1 | 4.6 | 3.9 | 2.7 | 6.6 | 3.6 | -5.8 | -107.7 | 3.3 | 4.8 | 11.1 |
P/CF |
-40.6 | -8.2 | -7.6 | -6.0 | -34.7 | -11.9 | -6.3 | -10.2 | -15.0 | -17.5 | -6.6 |
ROE % |
-43.38 | -59.22 | -63.06 | -25.10 | -27.95 | -45.48 | 118.38 | 6205.99 | -38.40 | -176.62 | -180.05 |
ROA % |
-26.50 | -37.80 | -44.85 | -24.22 | -23.88 | -34.11 | -123.69 | -231.68 | -37.00 | -162.01 | -140.88 |
ROCE % |
-49.51 | -27.82 | -42.24 | -24.20 | -26.85 | -35.69 | -149.86 | -62.61 | -38.41 | -54.69 | -180.43 |
Current Ratio |
4.6 | 9.3 | 7.7 | 23.9 | 8.7 | 20.9 | 5.3 | 12.0 | 27.3 | 12.0 | 4.6 |
DSO |
87.4 | 112.0 | 114.2 | - | - | - | - | 365.0 | - | 365.0 | 363.5 |
DIO |
47.4 | 52.1 | 421.3 | - | - | - | - | - | - | - | - |
DPO |
122.9 | 140.8 | 474.3 | - | - | - | 51433.9 | 36887.5 | - | - | - |
Операционный цикл |
134.8 | 164.0 | 535.5 | - | - | - | - | 365.0 | - | - | - |
Финансовый цикл |
11.9 | 23.2 | 61.3 | - | - | - | -51433.9 | -36522.5 | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -0.38 | -0.56 | -0.06 | - | -0.73 | -0.5 | -0.11 | - | -0.14 | -0.09 | -0.09 | - | -0.1 | -0.16 | -0.09 | - | -0.1 | -0.07 | -0.05 | - | -0.03 | -0.04 | -0.03 | - | -0.03 | -0.08 | -0.04 | - | -0.05 | -0.06 | -0.06 | - | -0.77 | -0.06 | -0.05 | - | -0.05 | -0.07 | -0.05 | - | -0.05 | -0.56 | -0.23 | - | -0.13 | -0.17 | -0.25 |
EBITDA per Share |
- | -0.43 | -0.56 | -0.05 | - | -0.46 | -0.55 | -0.12 | - | -0.15 | -85.3 | -87.3 | - | -105 | -159 | -85.6 | - | -104 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-31.36 | -43.17 | -46.55 | -42.40 | -33.01 | -53.80 | -62.79 | -66.12 | -41.81 | -55.36 | -48.11 | -58.65 | -45.95 | -53.95 | -48.39 | -32.55 | -16.63 | -20.82 | -17.01 | -17.90 | -14.85 | -23.00 | -26.96 | -36.55 | -32.62 | -6.26 | 28.26 | 78.52 | 90.41 | 5191.76 | 10266.73 | 10615.13 | 5827.82 | 5818.17 | 707.17 | 311.96 | -29.65 | -44.07 | -48.84 | -163.50 | -172.25 | -223.92 | -261.18 | -199.62 | -219.73 | -51.68 | -65.50 | -102.55 |
ROA % |
-17.16 | -24.66 | -28.10 | -26.45 | -21.68 | -34.96 | -40.72 | -42.73 | -26.69 | -36.32 | -32.69 | -40.96 | -32.68 | -40.40 | -38.48 | -28.58 | -16.05 | -19.63 | -15.49 | -15.66 | -12.69 | -18.80 | -21.33 | -27.87 | -24.46 | -52.01 | -73.44 | -97.53 | -94.46 | -284.91 | -447.80 | -426.13 | -217.56 | -226.86 | -45.72 | -43.37 | -28.57 | -41.80 | -45.72 | -150.33 | -158.00 | -198.43 | -225.63 | -160.34 | -171.92 | -40.43 | -51.25 | -80.24 |
ROCE % |
-31.59 | -39.55 | -37.21 | -34.05 | -31.97 | -54.85 | -69.78 | -72.26 | -44.54 | -59.12 | -50.81 | -61.57 | -47.64 | -55.60 | -48.98 | -27.32 | -7.96 | -7.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 2.9 | 4.1 | 4.2 | 4.6 | 5.1 | 5.3 | 5.7 | 5.3 | 5.3 | 5.3 | 5.3 | 11.4 | 11.4 | 11.4 | 11.4 | 28.7 | 28.7 | 28.7 | 28.7 | 6.9 | 6.9 | 6.9 | 6.9 | 4.0 | 4.0 | 4.0 | 4.0 | 0.5 | 0.5 | 0.5 | 0.5 | 1.0 | 1.0 | 1.0 | 1.0 | 27.4 | 27.4 | - | - | - | - | - | - | - | - | - | - |
DSO |
- | 101.9 | 108.3 | 100.1 | - | 62.9 | 73.9 | 83.4 | - | 99.9 | 158.7 | 79.5 | - | 42.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 90.7 | 91.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19923.5 | - |
DIO |
- | 124.2 | 122.2 | 68.3 | - | 69.5 | 99.0 | 84.2 | - | 67.7 | 49.2 | 83.8 | - | 156.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 82.7 | 151.3 | 145.2 | - | 158.1 | 172.3 | 174.2 | - | 183.2 | 133.0 | 124.8 | - | 176.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | 226.2 | 230.5 | 168.5 | - | 132.4 | 172.9 | 167.6 | - | 167.6 | 207.8 | 163.3 | - | 198.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 90.7 | 91.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19923.5 | - |
Финансовый цикл |
- | 143.5 | 79.3 | 23.3 | - | -25.8 | 0.6 | -6.6 | - | -15.5 | 74.8 | 38.6 | - | 22.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 90.7 | 91.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19923.5 | - |
Все данные представлены в валюте USD